BCL6 and B-cell non-Hodgkin lymphoma: Both IGH and RHOH are highly expressed in normal B cells indicating that the merger of the BCL6 SS domain with SE regions potentially represents a functional explanation for the aberrant upregulation of BCL6 in B-cell lymphoma.